CD22 Antikörper

Produktnummer ABIN7669997

Dieses Anti-CD22-Antikörper ist ein Maus Monoklonal-Antikörper zur Detektion von CD22 in FACS. Geeignet für Human.

Kurzübersicht für CD22 Antikörper (ABIN7669997)

Target: CD22 (CD22 Molecule (CD22))

Reaktivität: Human

Wirt: Maus

Klonalität: Monoklonal

Konjugat: Dieser CD22 Antikörper ist unkonjugiert

Applikation: Flow Cytometry (FACS)

Klon: LL2

Produktdetails anti-CD22 Antikörper

Verwendungszweck: Purified Anti-Human CD22 Antibody[LL2]

Aufreinigung: >98%, Protein A/G purified

Immunogen: Recombinant Human CD22 protein

Isotyp: IgG2a, kappa

Anwendungsinformationen

Applikationshinweise: FCM 2 μg/mL(1x10⁵-5x10⁵ cells)

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Konzentration: ≥ 1 mg/mL

Buffer: PBS, pH 7.2. Contains 0.05 % proclin 300.

Konservierungsmittel: ProClin

Vorsichtsmaßnahmen: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.

Handhabung: avoid freeze / thaw cycles.

Lagerung: 4 °C,-20 °C

Informationen zur Lagerung: Store at 4°C valid for 12 months or -20°C valid for long term storage, avoid freeze / thaw cycles.

Haltbarkeit: 12 months

Details zu CD22

Target: CD22 (CD22 Molecule (CD22))

Andere Bezeichnung: CD22

Hintergrund: Lyb,SIGLEC2FLJ,B-cell receptor CD,T-cell surface antigen Leu,sialic acid binding Ig-like lectin,Sialic acid-binding Ig-like lectin,CD22,SIGLEC-2,SIGLEC2,B-cell receptor CD22,BL-CAM,B-lymphocyte cell adhesion molecule,CD22 antigenMGC130020,CD22 Molecule,Lyb-8,sialic acid binding Ig-like lectin 2,Sialic acid-binding Ig-like lectin 2,SIGLEC2FLJ22814,T-cell surface antigen Leu-14,Siglec-2,CD22 Molecule,B cell receptor CD22 precursor,B lymphocyte cell adhesion molecule,BL CAM,BLCAM,CD 22,CD22 antigen,CD22 protein,Lectin 2,Leu14,Lyb8,MGC130020,sialic acid binding Ig like lectin 2,Sialic acid binding immunoglobulin like lectin 2,SIGLEC 2,T cell surface antigen Leu 14,Siglecs (sialic acid binding Ig-like lectins) are I-type (Ig-type) lectins belonging to the Ig superfamily. They are characterized by an N-terminal Ig-like V-type domain which mediates sialic acid binding, followed by varying numbers of Ig-like C2-type domains. Human Siglec-2, also known as B-cell antigen CD22 or Blymphocyte cell adhesion molecule (BL-CAM), is a B-cell restricted glycoprotein that is expressed in the cytoplasm of progenitor B and pre-B cells and on the surface of mature B cells. Two distinct human Siglec2/CD22 cDNAs that arise from differential RNA processing of the same gene have been isolated. Siglec2/CD22 is an adhesion molecule that preferentially binds alpha 2,6- linked sialic acid on the same (cis) or adjacent (trans) cells. Interaction of CD22 with trans ligands on opposing cells was found to be favored over the binding of ligands in cis.

UniProt: P20273